Who Wegovy Is For
Find out who Wegovy may be suitable for, including BMI guidance, eligibility and treatment considerations.
Published
Your account
Sign in to track orders, save wishlist items and check out faster.
Your account
Sign in to track orders, save wishlist items and check out faster.
To keep up to date on the latest news and special offers.
Find out who Wegovy may be suitable for, including BMI guidance, eligibility and treatment considerations.
Published
Wegovy is a prescription weight loss treatment designed for adults who may benefit from medical support with weight management. It is typically considered when lifestyle changes alone have not led to sustainable results, or when excess weight is affecting health and wellbeing.
Treatment is not based on one single factor. Clinicians look at the wider picture, including BMI, medical history, weight-related risks, and whether Wegovy is an appropriate option for the individual.
Wegovy is often considered for adults living with obesity, or for those who are overweight with health conditions linked to weight.
This may include people with a Body Mass Index (BMI) of:
Examples of weight-related conditions may include:
These thresholds can vary depending on clinical guidance and individual circumstances.
BMI can be a useful screening tool, but it does not tell the full story. Two people with the same BMI may have very different health risks, medical histories, and treatment needs.
That is why prescribing decisions should always consider:
A more personalised view is often more helpful than a number alone.
For some ethnic groups, health risks linked to weight can develop at lower BMI levels. This is particularly relevant for people from South Asian, Chinese, Black African, Black Caribbean, and other minority ethnic backgrounds.
For example, the risk of type 2 diabetes or cardiovascular disease may increase at a lower BMI compared with white European populations.
This means clinicians may use adjusted thresholds or take ethnicity into account when assessing suitability for treatment.
The aim is not to apply different rules unfairly. It is to recognise that risk does not look the same for everyone.
Wegovy may be appropriate for people who:
For many people, treatment can help make consistent progress feel more achievable.
There are situations where Wegovy may not be the right option, or where extra caution is needed.
This can include:
A clinician will review this before prescribing.
Even if you believe you meet the usual criteria, a proper consultation is still essential.
This allows a qualified prescriber to assess:
Good prescribing should always be individual, not automatic.
No. While Wegovy is often associated with higher BMI ranges, some people who are overweight with related health risks may also be eligible.
The decision depends on overall health impact, not just appearance or a headline number.
Wegovy is designed for adults who may benefit from medical support with weight management, particularly where weight is affecting health or previous efforts have not been sustainable.
BMI matters, but it is only part of the picture.
The best way to know whether Wegovy is right for you is through a safe, clinician-led assessment that considers your full circumstances.